# CTCs for High Grade Glioma

> **NCT02558335** · — · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 30 (estimated)

## Conditions studied

- Stage III and IV Glioma Patients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02558335
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2017-04
- **Final completion:** 2020-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02558335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02558335, "CTCs for High Grade Glioma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02558335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*